Disease/Infection News

RSS

Call for pharmaceutical companies to release COVID-19 vaccine data

Scientists are beginning to grow worried about the seeming reluctance of these companies to release the raw data from the clinical trials.

21 Jan 2022

Patient, beware: Some states still pushing ineffective covid antibody treatments

As the omicron variant completes its sweep across the U.S., states with scarce supplies of monoclonal antibody therapies continue to use two treatments that federal health officials warn no longer work against the highly contagious version of the virus that causes covid-19.

21 Jan 2022

Study explores whether gut bacteria profiles differ by race and insulin sensitivity status

In the present study published in PLOS ONE, researchers designed and undertook a unique study to investigate these interactions further.

21 Jan 2022

Cannabidiol found to inhibit SARS-CoV-2 infection in human cells and mice

An interdisciplinary team of researchers from the University of Chicago has found evidence that cannabidiol (CBD), a product of the cannabis plant, can inhibit infection by SARS-CoV-2 in human cells and in mice.

21 Jan 2022

Hospitalization risk high for IBD patients with incomplete COVID-19 vaccinations

The Crohn's & Colitis Foundation and the American Gastroenterological Association (AGA) are bringing together the inflammatory bowel disease (IBD) care community for the fifth annual Crohn's & Colitis Congress®, taking place virtually Jan. 20 through 22, 2022.

21 Jan 2022

New production method developed to freeze-dry COVID-19 vaccines

UMass Lowell scientists are developing a production method to freeze-dry COVID-19 vaccines activated by messenger-RNA so they can be transported and stored at room temperature.

21 Jan 2022

PAXLOVID shown to be highly effective against all SARS-CoV-2 variants

A recent study, currently available on bioRxiv* preprint server, shows that a novel protease inhibitor known as nirmatrelvir has potent activity against Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but also other variants evaluated in this paper – which supports its potential role in reducing the disease burden from coronavirus disease 2019 (COVID-19).

21 Jan 2022

COVID-19 vaccination does not impair fertility, suggests BU study

New findings by Boston University School of Public Health investigators indicate that COVID-19 vaccination does not impair fertility - but males who become infected by the coronavirus may experience short-term reduced fertility.

21 Jan 2022

Study evaluates socio-economic burden imposed on Chinese healthcare system during COVID

In a recent study published in the journal Public Health, a research team from China has evaluated and presented the economic burden of public healthcare and hospitalization associated with COVID-19 in China.

20 Jan 2022

Study uncovers clue to why pigs don't get sick when exposed to COVID-19

Iowa State University scientists may have uncovered an important clue that sheds light on why pigs don't get sick when exposed to the coronavirus

20 Jan 2022

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

In their recent study posted to the preprint server bioRxiv*, the researchers from China have shown that tuftsin, a natural phagocytosis-stimulating peptide, can effectively impair the binding of SARS-CoV-2 spike S1 subunit to ACE2 receptor in a dose-dependent manner and therefore can be considered a potential drug against SARS-CoV-2 infection.

20 Jan 2022

A validated risk-stratification system to manage COVID-19 outpatients

A group of researchers developed a risk-stratification system from existing scoring methods that are exclusively for outpatients.

20 Jan 2022

Indian study suggests significant decrease in protection from vaccine or natural immunity against Omicron variant

Researchers present evidence for early community transmission of the SARS-CoV-2 Omicron variant in New Delhi, India.

20 Jan 2022

Research shows benefits of hybrid immunity to SARS-CoV-2

Researchers examine the effects of previous SARS-CoV-2 infections on the immunity offered by SARS-CoV-2 vaccination.

20 Jan 2022

SARS-CoV-2 breakthrough infections elicit potent neutralizing antibody responses

A recent study looked at the strength, durability and breadth of neutralizing antibody responses generated by breakthrough infections in individuals vaccinated against SARS-CoV2.

20 Jan 2022

Experts highlight the neurological effects of SARS-CoV-2 and the need for rigorous research

SARS-CoV-2 was initially identified as a respiratory virus, but it can affect the entire body, including the nervous system.

20 Jan 2022

COVID-19 vaccination does not appear to impair fertility, study says

COVID-19 vaccination does not affect the chances of conceiving a child, according to a study of more than 2,000 couples that was funded by the National Institutes of Health.

20 Jan 2022

New report reveals the alarming global impact of Group B streptococcus

A new report from the World Health Organization (WHO) and the London School of Hygiene & Tropical Medicine (LSHTM) reveals the alarming global impact of Group B streptococcus (GBS) – a common bacterium that can be transmitted in the womb, during birth, or in the early weeks of life – leading to around 150,000 deaths of babies each year, more than half a million preterm births and significant long-term disability.

20 Jan 2022

Could heart rate be a risk factor for dementia?

In this interview, we speak to Dr. Yume Imahori about her latest research which looks at whether heart rate could be used as an early risk factor for dementia.

20 Jan 2022

Researchers explore furin inhibitors as a potential tool for treating COVID-19 infection

A new study suggests that coronaviruses such as SARS-CoV-2 depend on a furin cleavage site between the S1/S2 subunits to enhance viral infectivity.

20 Jan 2022

Disease/Infection News

Call for pharmaceutical companies to release COVID-19 vaccine data

Patient, beware: Some states still pushing ineffective covid antibody treatments

Study explores whether gut bacteria profiles differ by race and insulin sensitivity status

Cannabidiol found to inhibit SARS-CoV-2 infection in human cells and mice

Hospitalization risk high for IBD patients with incomplete COVID-19 vaccinations

New production method developed to freeze-dry COVID-19 vaccines

PAXLOVID shown to be highly effective against all SARS-CoV-2 variants

COVID-19 vaccination does not impair fertility, suggests BU study

Study evaluates socio-economic burden imposed on Chinese healthcare system during COVID

Study uncovers clue to why pigs don't get sick when exposed to COVID-19

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

A validated risk-stratification system to manage COVID-19 outpatients

Indian study suggests significant decrease in protection from vaccine or natural immunity against Omicron variant

Research shows benefits of hybrid immunity to SARS-CoV-2

SARS-CoV-2 breakthrough infections elicit potent neutralizing antibody responses

Experts highlight the neurological effects of SARS-CoV-2 and the need for rigorous research

COVID-19 vaccination does not appear to impair fertility, study says

New report reveals the alarming global impact of Group B streptococcus

Could heart rate be a risk factor for dementia?

Researchers explore furin inhibitors as a potential tool for treating COVID-19 infection

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News